A new endothelial target for cannabinoids.
Randall
Michael D
MD
School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, United Kingdom.
D000818:Animals; D001095:Arachidonic Acids / Q000494:pharmacology; D001685:Biological Factors / Q000378:metabolism; D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D004730:Endothelium, Vascular / Q000378:metabolism*; D005231:Fatty Acids, Unsaturated / Q000378:metabolism*; D006801:Humans; D053284:Polyunsaturated Alkamides; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug / Q000378:metabolism
D001095:Arachidonic Acids; D001685:Biological Factors; D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D005231:Fatty Acids, Unsaturated; D053284:Polyunsaturated Alkamides; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug; C067410:endothelium-dependent hyperpolarization factor; C078814:anandamide